Skip Ribbon Commands
Skip to main content

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The next big thing for New England’s real estate investors 

Frank Petz, Managing Director of JLL’s New England Capital Markets team tells JLL’s Investor why the Life Sciences product investment market has grown from unique, niche asset to a commodity, and what​ that means for real estate investors.​


​​​

​What​'s new in Capital Markets?​​

​​National Research​

 

 

United States Lodging Investment Outlook - Q3 2016/united-states/en-us/research/7757/us-lodging-investment-outlook-q3-2016-jllUnited States Lodging Investment Outlook - Q3 2016JLL expects the U.S. as a whole to sustain positive RevPAR growth, notwithstanding the recent trend of softening performance in some gateway markets. More M&A activity is expected throughout the sector. 
United States Investment Outlook - Q3 2016/united-states/en-us/research/7756/us-investment-outlook-q3-2016-jllUnited States Investment Outlook - Q3 2016Moderating volatility increases investor optimism heading into 2017. Pricing will be a key factor to watch. Read more in JLL's Q3 U.S. Investment Outlook.
United States Multifamily Investment Outlook - Q3 2016/united-states/en-us/research/7758/us-multifamily-investment-outlook-q3-2016-jllUnited States Multifamily Investment Outlook - Q3 2016The multifamily sector remains resilient, supported by job growth, sustained rental gains spurred by positive absorption, balanced housing starts and overall investor appetite for secondary markets.
United States Office Investment Outlook - Q3 2016/united-states/en-us/research/7685/us-office-investment-outlook-q3-2016-jllUnited States Office Investment Outlook - Q3 2016​Nationally, the overall pricing landscape for office product remains steady, with cap rates across primary and secondary markets averaging 4.4 percent.